Heartflow, Inc.

HTFL ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023
Operating Activities
Net Income $-116.8M $-96.4M $-95.7M
Depreciation & Amortization $5.4M $5.4M $4.7M
Depreciation
Amortization
Stock-Based Compensation $14.0M $10.2M $11.9M
Net Cash from Operating Activities $-54.0M $-69.0M $-76.4M
Investing Activities
Capital Expenditures $5.0M $4.4M $6.1M
Business Acquisitions
Net Cash from Investing Activities $-238.6M $-4.4M $-6.1M
Financing Activities
Dividends Paid
Stock Repurchases $228.0K
Net Cash from Financing Activities $286.0M $2.2M $169.3M
Net Change in Cash $-6.4M $-71.4M $86.3M
Free Cash Flow $-59.0M $-73.4M $-82.5M